Editorial
doi: 10.1001/jama.290.21.2859.
The return on INVEST
- PMID: 14657071
- DOI: 10.1001/jama.290.21.2859
Item in Clipboard
Editorial
The return on INVEST
JAMA.
.
Erratum in
- JAMA. 2004 Feb 25;291(8):944
No abstract available
Comment on
-
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.
Similar articles
-
[Hypertension therapies compared. Are the new nevertheless better than the old?].MMW Fortschr Med. 2005 Mar 24;147(12):6, 8. MMW Fortschr Med. 2005. PMID: 15832780 German. No abstract available.
-
Clinical inquiries. What is the best regimen for newly diagnosed hypertension?J Fam Pract. 2005 Mar;54(3):281-2. J Fam Pract. 2005. PMID: 15755386 Review. No abstract available.
-
[Antihypertensive drug therapy in diabetes mellitus].Z Arztl Fortbild (Jena). 1990;84(21):1109-10. Z Arztl Fortbild (Jena). 1990. PMID: 1980768 German. No abstract available.
-
Hypertension in the elderly: treatment.Cardiol Clin. 1986 May;4(2):245-52. Cardiol Clin. 1986. PMID: 2871936 Review.
-
A rational approach to hypertension treatment in the older patient.Geriatrics. 1992 Nov;47(11):24-8, 33-8. Geriatrics. 1992. PMID: 1358761 Review. No abstract available.
Cited by
-
Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.Vasc Health Risk Manag. 2007;3(4):453-65. Vasc Health Risk Manag. 2007. PMID: 17969376 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
